Healthcare Business News, July 1 2020 — With the COVID-19 pandemic pushing breast cancer screening to the back burner for many patients, scanner and software manufacturers have more reason than ever to bring products to the market that make scans faster and more comfortable, and helping radiologists manage their growing worklists. Here’s a look at what’s new in the last year from more than a dozen companies.

Koios Medical, Inc.

Last July, Koios announced FDA clearance of its Koios DS Breast 2.0, AI-based decision support software that assists radiologists in analyzing and classifying suspicious breast ultrasound images.

The software provides an AI-generated finding, providing a probability of malignancy within the appropriate BI-RADS category and descriptors for reporting.

“When using ultrasound, something is suspicious.” said Chad McClennan, president and chief executive officer of Koios. “Koios DS is an instantaneous second opinion for those cases.”

The software’s ensemble of algorithms has been trained on hundreds of thousands of images from a variety of patient demographic profiles derived from a wide range of ultrasound system manufacturers, and McClennan says customers have seen workflow improvements combined with a reduction in benign biopsies and avoidable, unnecessary follow-up appointments, while catching more cancers earlier.

Read the full article in DOTmed’s Healthcare Business News July issue.